Breaking News Headlines Today | Ground News

See every side of every news story

lifesciencesbc.ca image

News from lifesciencesbc.ca

Ground News rates lifesciencesbc.ca’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

lifesciencesbc.ca’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about lifesciencesbc.ca

Where is lifesciencesbc.ca located?lifesciencesbc.ca's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top lifesciencesbc.ca News

ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA

Cancer · St. Catharines

ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA

67% Left coverage: 18 sources

SAN CARLOS, Calif.--(BUSINESS WIRE)--Jan 6, 2026-See the Story

Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment

Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment

Johnson & Johnson (NYSE:JNJ) on Tuesday shared topline results from the Phase 2b JASMINE study of nipocalimab in lupus patients. The systemic lupus erythematosus (SLE) is a chronic autoimmune disease where the body's immune system attacks healthy tissues and organs, causing inflammation in various…See the Story

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

Health Canada · British Columbia

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

NORTH CHICAGO, Ill., Jan. 7, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2025 financial results on Wednesday, February 4, 2026, before the market opens. AbbVie will host a live webcast of the earnings conference call…See the Story

Breaking News Topics Related to lifesciencesbc.ca